All Eyes on NVIDIA - US Markets Slightly Down - DAX Investors Cautious - Rate cut in December is uncertain - Buffett Invests in Alphabet - Jazz Pharmaceuticals and Zymeworks Succeed with Cancer Medication - Novo Nordisk Undercuts Eli Lilly - XPeng Exceeds Expectations - Elbit Systems Secures a Major Contract

NVIDIA – The US chip giant comes into the spotlight: Wall Street holds back before quarterly results – Labor market data and AI valuations shape market outlook for 2025 Wall Street traders are preparing for NVIDIA's (-1.59%) quarterly results and an important labor market report , opting out of riskier bets as both events will be crucial for market prospects for the rest of 2025. Stocks fluctuate at the beginning of the week, with the S&P 500 continuing to trade in the red in November and on track to end a series of six consecutive...